How is hamartoma treated?

Hamartomas have long been considered by most scholars not to be true neoplasms, but rather disorganized and aberrant arrangements of normal tissue elements within an organ. These abnormalities—manifesting as disturbances in the quantity, structure, or degree of maturation of the constituent tissues—typically grow slowly alongside the individual’s development and rarely undergo malignant transformation. So, how are hamartomas treated? The following section addresses this question.

How Are Hamartomas Treated?

1. Surgical Treatment

Pulmonary hamartomas are predominantly benign, with malignancy occurring in only approximately 0.5% of cases. However, because pulmonary hamartomas can sometimes be difficult to distinguish radiologically from peripheral lung cancer, early surgical resection is generally recommended. In middle-aged and elderly patients presenting with a solitary pulmonary lesion whose benign nature cannot be definitively confirmed, surgical exploration is advised. For most pulmonary hamartoma cases, tumor enucleation or wedge resection of the lung is appropriate. If the tumor is located centrally near the hilum, is very large, is densely adherent to hilar bronchi or vessels, or has already caused irreversible pathological changes in the distal lung parenchyma, lobectomy may be indicated.

2. Close Surveillance

For renal hamartomas (angiomyolipomas), conservative management with close surveillance is appropriate for tumors <4 cm in diameter. In cases complicated by hemorrhage, selective arterial embolization should be considered. Although embolization typically does not reduce tumor volume, it effectively controls bleeding. Superselective renal artery branch embolization is preferred to preserve residual renal function. Furthermore, nephron-sparing surgery—including tumor enucleation—is feasible for lesions <5 cm, particularly those located at the renal periphery. For massive renal hamartomas, radical nephrectomy may be required.

3. Surgical Resection

Surgical resection remains the treatment of choice for hepatic hamartomas. Because these lesions usually exhibit well-defined margins from surrounding normal liver tissue, simple tumor enucleation is often sufficient. When the tumor is densely adherent to adjacent hepatic parenchyma, partial hepatectomy or lobectomy may be necessary. Moreover, children’s livers typically lack cirrhosis and possess strong regenerative capacity, facilitating extensive hepatic resection when needed. Similarly, breast hamartomas warrant prompt surgical excision. Definitive diagnosis is established via postoperative paraffin-embedded histopathological examination, and recurrence after complete resection is uncommon.

The above outlines current approaches to the treatment of hamartomas. We hope this information is helpful to you.